Quarterly Result14 May 2026, 11:01 pm
Sai Life Sciences: FY26 Revenue at ₹21,532.26 Mn
AI Summary
Sai Life Sciences Ltd. announced its audited financial results for the year ended March 31, 2026. The Board of Directors approved the standalone and consolidated financial results in a meeting held on May 14, 2026. Revenue from operations for FY26 stood at ₹21,532.26 million compared to ₹16,420.48 million in FY25. The company's profit for the year was ₹3,414.81 million, up from ₹1,734.62 million in the previous year. Basic earnings per share increased to ₹16.27 from ₹9.00.
Key Highlights
- FY26 revenue from operations reached ₹21,532.26 million, a significant increase from ₹16,420.48 million in FY25.
- The company's profit for FY26 was ₹3,414.81 million, substantially higher than ₹1,734.62 million in FY25.
- Basic earnings per share for FY26 rose to ₹16.27, compared to ₹9.00 in the previous fiscal year.
- The Board of Directors approved the audited financial results at a meeting held on May 14, 2026.
- Auditors Report of the Statutory Auditors, M/s. Deloitte Haskins & Sells LLP, was noted for the quarter and financial year ended 31 March 2026.